PuSH - Publication Server of Helmholtz Zentrum München: International Lung Cancer Consortium: Coordinated association study of 10 potential lung cancer susceptibility variants.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Truong, T.* ; Sauter, W. ; McKay, J.D.* ; Hosgood, H.D.* ; Gallagher, C.* ; Amos, C.I.* ; Spitz, M.* ; Muscat, J.* ; Lazarus, P.* ; Illig, T. ; Wichmann, H.-E. ; Bickeböller, H.* ; Risch, A.* ; Dienemann, H.* ; Zhang, Z.F.* ; Naeim, B.P.* ; Yang, P.* ; Zienolddiny, S.* ; Haugen, A.* ; Le Marchand, L.* ; Hong, Y.C.* ; Kim, J.H.* ; Duell, E.J.* ; Andrew, A.S.* ; Kiyohara, C.* ; Shen, H.B.* ; Matsuo, K.* ; Suzuki, T.* ; Seow, A.* ; Ng, D.P.K.* ; Lan, Q.* ; Zaridze, D.* ; Szeszenia-Dabrowska, N.* ; Lissowska, J.* ; Rudnai, P.* ; Fabianova, E.* ; Constantinescu, V.* ; Bencko, V.* ; Foretova, L.* ; Janout, V.* ; Caporaso, N.E.* ; lbanes, D.* ; Thun, M.* ; Landi, M.T.* ; Trubicka, J.* ; Lener, M.* ; Lubinski, J.* ; EPIC-lung Consortium (*) ; Wang, Y.* ; Chabrier, A.* ; Boffetta, P.* ; Brennan, P.* ; Hung, R.J.*

International Lung Cancer Consortium: Coordinated association study of 10 potential lung cancer susceptibility variants.

Carcinogenesis 31, 625-633 (2010)

DOI

PMC

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

BACKGROUND: Analysis of candidate genes in individual studies has had only limited success in identifying particular gene variants that are conclusively associated with lung cancer risk. In the International Lung Cancer Consortium (ILCCO), we conducted a coordinated genotyping study of 10 common variants selected because of their prior evidence of an association with lung cancer. These variants belonged to candidate genes from different cancer-related pathways including inflammation (IL1B), folate metabolism (MTHFR), regulatory function (AKAP9 and CAMKK1), cell adhesion (SEZL6) and apoptosis (FAS, FASL, TP53, TP53BP1 and BAT3). METHODS: Genotype data from 15 ILCCO case-control studies were available for a total of 8431 lung cancer cases and 11 072 controls of European descent and Asian ethnic groups. Unconditional logistic regression was used to model the association between each variant and lung cancer risk. RESULTS: Only the association between a non-synonymous variant of TP53BP1 (rs560191) and lung cancer risk was significant (OR = 0.91, P = 0.002). This association was more striking for squamous cell carcinoma (OR = 0.86, P = 6 x 10(-4)). No heterogeneity by center, ethnicity, smoking status, age group or sex was observed. In order to confirm this association, we included results for this variant from a set of independent studies (9966 cases/11,722 controls) and we reported similar results. When combining all these studies together, we reported an overall OR = 0.93 (0.89-0.97) (P = 0.001). This association was significant only for squamous cell carcinoma [OR = 0.89 (0.85-0.95), P = 1 x 10(-4)]. CONCLUSION: This study suggests that rs560191 is associated to lung cancer risk and further highlights the value of consortia in replicating or refuting published genetic associations.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

4.795

1.650